Digital twin company Twin Health secures $50M

Digital metabolic care startup Twin Health has raised $50 million in funding, led by Temasek, with participation from existing investors Sofina, ICONIQ Growth, Helena, and Peak XV.

This comes two years after the company secured $140 million in Series C funding. Twin Health's flagship product is the Whole Body Digital Twin, an AI-backed model designed to offer personalised nutrition, sleep, and activity recommendations to help individuals prevent and reverse metabolic diseases like Type 2 diabetes. 

The funding will support Twin Health's strategy to expand the availability and deployment of its transformative technology to more health plans and employer partners, aiming for lower costs, better outcomes, and higher satisfaction among members and employees.

According to a survey conducted by TATA Consultancy Services earlier this year, experts predict that digital twins will reshape society by 2035, with widespread adoption in healthcare within the next six years. Twin Health is not the only company in the digital twin space; Singaporean startup Mesh Bio focuses on using digital twins to manage chronic diseases, particularly in Southeast Asia. 

Another player, Unlearn, a clinical trial tech company, employs a machine learning model to create digital twins of randomised controlled trial participants, facilitating quicker and smaller clinical trials by eliminating the need for as many participants in the control group. Last year, Unlearn secured $50 million in Series B funding, bringing its total funding to nearly $70 million.